CHLORHEXIDINE HYDROCHLORIDE 0.1% AND NEOMYCIN SULFATE 0.5% (Naseptin®)

Clinical Indication

MRSA decolonization (to match current guidelines)

Comments

MRSA decolonisation for patients unable to tolerate mupirocin (Bactroban) and where mupirocin resistance is identified.

Date of classification

October 2023

Green

Medicines which could be started in any health care setting and do not require oversight by a specialist and which primary care would have full responsibility for prescribing and monitoring.